Profusa Inc (PFSA)

$0.27 -0.02 (-7.29%)
Market Cap 1.25M
Revenue (ttm) 0.00
Net Income (ttm) -35.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.17
Volume 230,167
Avg Vol 6,036,370
Day's Range N/A - N/A
Shares Out 4.66M
Stochastic %K 25%
Beta 0.35
Analysts Strong Buy
Price Target N/A

Company Profile

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berk...

Industry: Medical Devices
Sector: Healthcare
Phone: 925 997 6925
Website: profusa.com
Address:
626 Bancroft Way, Suite A, Berkeley, United States
ericus20
ericus20 Jun. 8 at 11:28 PM
$PFSA $RDAC primed and ready to go!!!!!
0 · Reply
alby777
alby777 Jun. 3 at 4:45 PM
$PFSA M&A!?
0 · Reply
alby777
alby777 Jun. 3 at 2:08 PM
$PFSA Abbott Labs Buys PFSA!? Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.... M&A!?
0 · Reply
alby777
alby777 Jun. 3 at 1:59 PM
$PFSA M&A!? Potential Buyers, Senseonics Holdings, Autonomix Medical, Abbott Laboratories, and or Cambridge Medical Technologies. M&A!?
0 · Reply
NewNewOld
NewNewOld Jun. 3 at 8:52 AM
$PFSA and mullen automotive i found new similar shit like you. $SOAR
0 · Reply
alby777
alby777 Jun. 2 at 8:29 PM
$PFSA M&A? Ascent Partners Fund LLC regularly buys PFSA (Profusa, Inc.) stock. Under an Equity Line of Credit (ELOC) and ongoing Securities Purchase Agreements (initially formed in July 2025 and amended multiple times), Profusa has been authorized to sell up to \(\$100\text{ million}\) in common stock to Ascent.Recent transactions and updates include:May 2026: Profusa submitted an Advance Notice requesting that Ascent purchase up to \(9.99\%\) of their outstanding shares per notice (capped at \(\$300,000\) per transaction)
0 · Reply
alby777
alby777 Jun. 2 at 5:05 PM
$PFSA M&A? There are no active buyout offers or official proposals for PFSA. Rather than being acquired, the digital health company is focused on its own acquisitions and partnerships to scale its tissue-integrated biosensor technologies, such as its recent multi-omics platform integration and collaboration with the Mayo Clinic.
0 · Reply
alby777
alby777 Jun. 2 at 3:00 PM
$PFSA M&A!? Which giant Pharma co. will Buy PFSA!? https://investors.profusa.com/email-alerts
0 · Reply
alby777
alby777 Jun. 2 at 2:46 PM
$PFSA https://materials.proxyvote.com/Approved/74319X/20260512/FO10K_635862.PDF
0 · Reply
alby777
alby777 Jun. 2 at 2:45 PM
$PFSA PROFUSA, INC. June 23, 2026 Annual Meeting Vote Shares by June 22, 2026
0 · Reply
Latest News on PFSA
Profusa to transfer listing to Nasdaq

2026-05-15T14:05:41.000Z - 25 days ago

Profusa to transfer listing to Nasdaq

Profusa Announces Listing Transfer to The Nasdaq Capital Market

May 15, 2026, 7:30 AM EDT - 25 days ago

Profusa Announces Listing Transfer to The Nasdaq Capital Market

Profusa receives favorable Nasdaq listing determination

2026-05-08T10:07:48.000Z - 4 weeks ago

Profusa receives favorable Nasdaq listing determination

Profusa Receives Favorable Nasdaq Listing Determination

May 8, 2026, 6:00 AM EDT - 4 weeks ago

Profusa Receives Favorable Nasdaq Listing Determination

Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value

May 5, 2026, 8:30 AM EDT - 5 weeks ago

Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value

Profusa announces $30M letter of intent for PanOmics diagnostic platform

2026-04-06T10:05:05.000Z - 2 months ago

Profusa announces $30M letter of intent for PanOmics diagnostic platform

Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Apr 6, 2026, 6:00 AM EDT - 2 months ago

Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Feb 27, 2026, 9:15 AM EST - 3 months ago

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Feb 19, 2026, 8:30 AM EST - 3 months ago

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Feb 13, 2026, 8:30 AM EST - 4 months ago

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Profusa Announces 1-for-75 Reverse Stock Split

Feb 5, 2026, 8:00 AM EST - 4 months ago

Profusa Announces 1-for-75 Reverse Stock Split

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Jan 29, 2026, 8:00 AM EST - 4 months ago

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Jan 16, 2026, 7:30 AM EST - 5 months ago

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Jan 8, 2026, 7:30 AM EST - 5 months ago

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Dec 31, 2025, 7:30 AM EST - 5 months ago

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Here’s Why Profusa Stock (PFSA) Rocketed Today

2025-12-30T14:56:15.000Z - 5 months ago

Here’s Why Profusa Stock (PFSA) Rocketed Today

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Dec 30, 2025, 7:30 AM EST - 5 months ago

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Dec 15, 2025, 7:30 AM EST - 6 months ago

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Dec 11, 2025, 8:30 AM EST - 6 months ago

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Nov 24, 2025, 8:15 AM EST - 7 months ago

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Profusa Announces Third Quarter Business and Financial Highlights

Nov 19, 2025, 5:44 PM EST - 7 months ago

Profusa Announces Third Quarter Business and Financial Highlights

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Oct 30, 2025, 7:30 AM EDT - 7 months ago

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Oct 28, 2025, 8:30 AM EDT - 8 months ago

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Oct 22, 2025, 8:30 AM EDT - 8 months ago

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Profusa Invests Additional $1 Million in Digital Treasury Assets

Oct 7, 2025, 8:15 AM EDT - 8 months ago

Profusa Invests Additional $1 Million in Digital Treasury Assets

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Oct 1, 2025, 8:30 AM EDT - 8 months ago

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Sep 11, 2025, 8:30 AM EDT - 9 months ago

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Sep 4, 2025, 8:30 AM EDT - 9 months ago

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Aug 27, 2025, 8:45 AM EDT - 10 months ago

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Aug 19, 2025, 8:15 AM EDT - 10 months ago

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Aug 6, 2025, 8:15 AM EDT - 10 months ago

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Jul 31, 2025, 8:15 AM EDT - 11 months ago

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Jul 21, 2025, 8:00 AM EDT - 11 months ago

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Jul 11, 2025, 4:00 PM EDT - 11 months ago

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

ericus20
ericus20 Jun. 8 at 11:28 PM
$PFSA $RDAC primed and ready to go!!!!!
0 · Reply
alby777
alby777 Jun. 3 at 4:45 PM
$PFSA M&A!?
0 · Reply
alby777
alby777 Jun. 3 at 2:08 PM
$PFSA Abbott Labs Buys PFSA!? Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.... M&A!?
0 · Reply
alby777
alby777 Jun. 3 at 1:59 PM
$PFSA M&A!? Potential Buyers, Senseonics Holdings, Autonomix Medical, Abbott Laboratories, and or Cambridge Medical Technologies. M&A!?
0 · Reply
NewNewOld
NewNewOld Jun. 3 at 8:52 AM
$PFSA and mullen automotive i found new similar shit like you. $SOAR
0 · Reply
alby777
alby777 Jun. 2 at 8:29 PM
$PFSA M&A? Ascent Partners Fund LLC regularly buys PFSA (Profusa, Inc.) stock. Under an Equity Line of Credit (ELOC) and ongoing Securities Purchase Agreements (initially formed in July 2025 and amended multiple times), Profusa has been authorized to sell up to \(\$100\text{ million}\) in common stock to Ascent.Recent transactions and updates include:May 2026: Profusa submitted an Advance Notice requesting that Ascent purchase up to \(9.99\%\) of their outstanding shares per notice (capped at \(\$300,000\) per transaction)
0 · Reply
alby777
alby777 Jun. 2 at 5:05 PM
$PFSA M&A? There are no active buyout offers or official proposals for PFSA. Rather than being acquired, the digital health company is focused on its own acquisitions and partnerships to scale its tissue-integrated biosensor technologies, such as its recent multi-omics platform integration and collaboration with the Mayo Clinic.
0 · Reply
alby777
alby777 Jun. 2 at 3:00 PM
$PFSA M&A!? Which giant Pharma co. will Buy PFSA!? https://investors.profusa.com/email-alerts
0 · Reply
alby777
alby777 Jun. 2 at 2:46 PM
$PFSA https://materials.proxyvote.com/Approved/74319X/20260512/FO10K_635862.PDF
0 · Reply
alby777
alby777 Jun. 2 at 2:45 PM
$PFSA PROFUSA, INC. June 23, 2026 Annual Meeting Vote Shares by June 22, 2026
0 · Reply
ShadowSnake
ShadowSnake Jun. 2 at 1:03 PM
$PFSA 1:200!? FU
1 · Reply
Hydrojim
Hydrojim May. 29 at 3:09 AM
$PFSA
0 · Reply
focafoca99
focafoca99 May. 26 at 3:43 PM
$PFSA amended its asset purchase agreement, deleting the management‑share provision and issuing $30 M of Series A convertible preferred
0 · Reply
Cmash1
Cmash1 May. 22 at 7:03 PM
$ADTX $KIDZ $PFSA
0 · Reply
FinanceLegacy
FinanceLegacy May. 22 at 6:52 PM
$ADTX let’s squeeze here bottom inn same setup as $KIDZ $PFSA 🤑🤑
0 · Reply
Hydrojim
Hydrojim May. 20 at 11:38 PM
$PFSA
0 · Reply
Nuclear_Elvis
Nuclear_Elvis May. 20 at 7:29 PM
$PFSA If you read this SEC Filing in its entirety, you will get a sense of why I say that - the CEO should be forcibly demoted to Chief Technical Officer (CTO) at most, so he only worries about developing Medical Devices but is not allowed anywhere near the Accounting Books or Financial Deals of the company. CEO is a collosal failure - as CEO, even though he has skills in other lanes. https://www.sec.gov/Archives/edgar/data/1859807/000121390026058635/ea0291342-424b3_profusa.htm
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 19 at 11:15 PM
$PFSA interesting place to be
0 · Reply
Nuclear_Elvis
Nuclear_Elvis May. 19 at 5:01 PM
$PFSA Volume and price are way down. TOXIC and highly suggest staying away from this one. The Company has a Proxy out for an up-to 1-for-200 Reverse Split, which will be the second RS in the past 2 years. CEO may be a genius for Medical Devices and inventing them, but he is aloof and a screw-up for the fiscal responsibilities of a CEO (just look what he did to buy Bitcoin High and sell Low with company's cash).
0 · Reply
focafoca99
focafoca99 May. 18 at 9:43 PM
$PFSA announced an advance notice to Ascent Partners for a share purchase under its equity line of credit, permitting up to 9.99% of
0 · Reply
stopping
stopping May. 15 at 10:36 PM
$PFSA It’s over… there’s only $400,000 left in funds.
0 · Reply
alby777
alby777 May. 14 at 2:14 AM
$PFSA The Korean sentence "희석이나 병합얘기는 계속하면서 왜 비트코인 매각 이후에 대한 진행상황 얘기는 없는거죠? " can be translated into English as: "Why do they keep talking about dilution or mergers, but there is no news regarding the progress after selling Bitcoin?" The few that keep their shares and average down may be rewarded big time, or not!?
0 · Reply